ancestim: Clinical Trials

5 trials of ancestim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Terminated 1
Early Phase 11Unknown 1

Follow ancestim: new trials by email Literature Review of ancestim trials Research Report on ancestim

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
Lenalidomide + Ancestim - Myelodysplasia
Early Phase 1UnknownPeter MacCallum Cancer Centre, Australia252007-02-012013-01-10
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Recombinant-methionyl human stem cell factor - Hemoglobin SC Disease, Sickle Cell Anemia
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)502000-03-012008-03-04
Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma
r-metHuSCF and Filgrastim, Chemotherapy plus Filgrastim - Malignant Lymphoma
Phase 2TerminatedAalborg University Hospital321999-01-012015-06-25
Comparing Treatments for Multiple Myeloma
Stemgen - Multiple Myeloma
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)321998-09-012008-03-04
Stem Cell Factor Medication for Aplastic Anemia
Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) - Aplastic Anemia, Pancytopenia
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)401993-10-012008-03-04

Conditions studied

Anemia, Aplastic (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Anemia, Sickle Cell (1)  ·  Bone Marrow Failure Disorders (1)  ·  Hemoglobin SC Disease (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Pancytopenia (1)  ·  Vaso-Occlusive Crises (1)  ·  beta-Thalassemia (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Aalborg University Hospital (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Peter MacCallum Cancer Centre, Australia (1)

Countries

United States (3)  ·  Australia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Norway (1)  ·  Sweden (1)

Top investigators

Hans E Johnsen, MD DMSc (1)  ·  Miles Prince, Prof. (1)